Sökning: "brain natriuretic peptide"

Visar resultat 1 - 5 av 34 avhandlingar innehållade orden brain natriuretic peptide.

  1. 1. Nitrates and Left Ventricular Dysfunction

    Författare :Erik Tingberg; Kardiologi; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; lipid peroxidation; malondialdehyde; peptide; brain natriuretic peptide; left ventricular dysfunction; nitrates; acute myocardial infarction; heart failure; atrial natriuretic; diuretics; echocardiography; haemodynamic measurements; neurohumoral activation; diastolic dysfunction; Cardiovascular system; Medicin människa och djur ; Medicine human and vertebrates ; Kardiovaskulära systemet; oxidative stress; isoprostanes;

    Sammanfattning : Use of beta-blockers and inhibitors of the renin angiotensin system (RAS) is established practice in the treatment of chronic heart failure (CHF). Clinical studies also suggest beneficial long-term effects of nitrates in CHF. LÄS MER

  3. 2. Early Risk Stratification, Treatment and Outcome in ST-elevation Myocardial Infarction

    Författare :Erik Björklund; Bertil Lindahl; Lars Wallentin; Ulf Näslund; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Medicine; Acute myocardial infarction; Thrombolysis; Troponin; Electrocardiography; Natriuretic peptide; Prognosis; Prehospital thrombolysis; Treatment delay; Mortality; Registry; Clinical trial; Medicin; Dermatology and venerology; clinical genetics; internal medicine; Dermatologi och venerologi; klinisk genetik; invärtesmedicin;

    Sammanfattning : We evaluated, in patients with ST-elevation myocardial infarction (STEMI) treated with thrombolytics, admission Troponin T (tnT), ST-segment resolution and admission N-terminal pro-brain natriuretic peptide (NT-proBNP) for early risk stratification as well as time delays and outcome in real life patients according to prehospital or in-hospital thrombolytic treatment. Also, baseline characteristics, treatments and outcome in patients enrolled in the ASSENT-2 trial in Sweden and in patients not enrolled were evaluated. LÄS MER

  4. 3. Coagulation, Inflammation and Myocardial Dysfunction in Unstable Coronary Artery Disease and the Influence of Glycoprotein IIb/IIIa Inhibition and Low Molecular Weight Heparin

    Författare :Stefan James; Lars Wallentin; Agneta Siegbahn; Robbert de Winter; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Medicine; Acute coronary syndrome; Angina; Mortality; Myocardial infarction; Glycoprotein IIb IIIa inhibition; Troponin; C-reactive protein; Coagulation; Natriuretic peptide; Medicin; Dermatology and venerology; clinical genetics; internal medicine; Dermatologi och venerologi; klinisk genetik; invärtesmedicin; kardiologi; Cardiology;

    Sammanfattning : Hjärt-kärl sjukdom är den vanligaste dödsorsaken i västvärlden. Samtidigt som antalet patienter med hjärtinfarkt har minskat, har antalet patienter med instabil kranskärlsjukdom d.v.s. LÄS MER

  5. 4. Fluid Management in Haemodialysis : Studies on current practices and new methods

    Författare :Jenny Stenberg; Hans Furuland; Magnus Lindberg; Eva Tiensuu Janson; Bernd Stegmayr; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Haemodialysis; Fluid management; Fluid overload; Bioimpedance spectroscopy; Dry weight; Brain natriuretic peptide; Decision aid; Medicinsk vetenskap; Medical Science;

    Sammanfattning : Chronic fluid overload has been identified as an independent predictor of mortality in haemodialysis patients, and 30% remain fluid overloaded at dry weight. The use of bioimpedance spectroscopy (BIS) in fluid management may improve blood pressure control and cardiovascular status. LÄS MER

  7. 5. Peptide and non-peptide biomarkers of mortality in patients with advanced chronic kidney disease

    Författare :Jia Sun; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :;

    Sammanfattning : Over the last decade, multiple studies have attempted to identify better risk prediction tools specific to the chronic kidney disease (CKD) population. In many cases, these studies have evaluated the use of various peptide biomarkers as prediction tools. LÄS MER